Form 4 for NEO NEOGENOMICS INC
Accepted 2022-05-02 00:00:00 ET · period of report 2022-04-28 · accession 0001077183-22-000071 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-02 | 2022-04-28 | NEO | Bonello William | CFO | M - OptEx | $7.52 | +5,727 | 191.5K | +3% | +$43.1K |
| D | 2022-05-02 | 2022-04-28 | NEO | Bonello William | CFO | M - OptEx | $0.00 | -5,727 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-28 | M | A | 5,727 | $7.52 | 191,548 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-04-28 | M | D | 5,727 | $0.00 | 0 | D | $7.52 · — to 2022-04-28 | 5,727 Common Stock | (F1) On April 28, 2017, Mr. Bonello was granted 100,000 stock options. These options vested ratably over the first three anniversary dates of the grant date. |